{"name":"Design Therapeutics, Inc.","slug":"design-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DT-168","genericName":"DT-168","slug":"dt-168","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"DT-168","genericName":"DT-168","slug":"dt-168","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPRXpaOWktcUkzT2d1RER3Y1YyWmRTWWpBQ3RwSy12N2xYWl9yZ08tdnpMUklEN0hhMzExbnRLTGpsMFZrTXNtdnZ0ZDN3MmNURVpzenBmbHdLLS1kYk9FNzZjWW50TS02aGJsUTdDLXZpcVVJOWU4bjYxbzdCSk5wNzJhdlV4VGVRamhQVWs5UlBIZlhrbUZldmRtZzhZZml0UzljbFdDS0Y1LVp2c0xYMnJn?oc=5","date":"2026-04-01","type":"pipeline","source":"Stock Titan","summary":"David Shapiro joins Design Therapeutics (DSGN) board with equity awards - Stock Titan","headline":"David Shapiro joins Design Therapeutics (DSGN) board with equity awards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQWDZBRjYtczNJLWF1emN1QkEyekhMa3Y1SE9LQnVkdi1TWEg4YlhIYmFHMk9CWmRtTGUxNEJjOHEzTGN4Y2RkcVl3NmNKN0VnMXBsRlJKQ25YZDBGYWI0dEszaUZPclVNMXlEM3drTE9UOWxnblM5aEFYY1FkYWpiUGdQcVVJSlUyOFR6cVhLLV9UYWd4Z0l3VnBnSWgzM1k0MElHRXo2U2lSeHFfaWlsVjRzN0t0eWVY?oc=5","date":"2026-04-01","type":"pipeline","source":"Stock Titan","summary":"Director David Shapiro granted 67,500 DSGN stock options (DSGN) - Stock Titan","headline":"Director David Shapiro granted 67,500 DSGN stock options (DSGN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOMl9xSEpkeUExbFRIYy1ZbkV0a0ZmYVBGR24tOVNVekpqQXl4UE40UWRhZ0JoLTBDNy1GT1NlYmxTVGpfZlFIcFg3WmRfSXNmaDRJQXUyXzdxdlJtc0V4Vm1HOE9lUXBsWThqMldzNy1iZUZSWGV4NUp4V25kN1c3Y3N5VkhBek9tLThqS1I5LTVscVNXU1ZjODVhUkJJMVduUlpRY3FXX002Y0RlR3pCQ2RmTzlWSkExRDdkbW5kR2FJMURUZVRld3Z2X1hyMEJHczVxRmY2ZmNoTmZVWEVFYUJUOU45azh0OHgxVGg3bTVnT1B3cXJaQkN3X0JYU2xBREo0c0R3OXJ4cS10WUt4bmRXYWtsNmU4dW9uRHBwaUc?oc=5","date":"2026-03-11","type":"pipeline","source":"The Globe and Mail","summary":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail","headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-10","type":"earnings","source":"The Manila Times","summary":"Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates - The Manila Times","headline":"Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AJBVV95cUxNV0pUNGVDTEx6Ukkxa0pVbHkxbTEweFhCYmxzN1F3RTJhSDEzRnFjSkxDTzl3LVpmd2NOWERnb3ZUWjV0RWppN0VWOGpYd2MwMFhXWWYtekNNWW9UbGpDRS1ZTUE3Y1FaQ3Z4MzFucXh6cXBxTEdObjdsRHBRQldTeWR1a0tvYVFQZFpETURZOElma2ItaDBmSGw1TTNxTnZUUl9NanFVQ1lKSUNfU2djeDBMVW9Dc28wUG9qZzA2ckVjai1KdVFqWEg5ZXRyUHl3elZROW1wLThudHYzbEt5LVBiQUNMQTVFWVA1YUUxVnJQa1FxLUItdWN2c1dyNFExQUw1MEcxdWtxVFptRG90RlBGN3pVYndEOVQtc0tsNVZaQlRsWVBlM094a01TYm9rRm1ndHd1dV9jek9rUlNTYWdvVEV0eTg5MHg1X1ItbF9hVWV1UTVxOEJGWXBtVnpKX2xOWEdVaVd0VDFsVWxUMVBlX19wR0VmSUlKbg?oc=5","date":"2026-03-03","type":"pipeline","source":"Business Wire","summary":"Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic","headline":"Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Se","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQOW5fTjVrSEJzckkwOTl5dUpCMy1PaXZaTzcza2x0LW9Ka21GemdySnRyYXZucnIxZi00dnBsWE1XSkIxV2JuaUxEQkp4dGZJRWJTNlo0NVdKbjdseENuaG96STRPa3NWQmoxUXdEOVltRWRKTVdnVlJnMHVFcFJWWU9ZYm81MFdta0Z3dldB?oc=5","date":"2026-01-26","type":"pipeline","source":"Yahoo Finance","summary":"MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance","headline":"MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxONUtZWWRMT3BBeFphSzJ6SnBWdXB4c19KSmJSekU4bXlkNW8zN2dub1YxSDkwdXNUTEZRcHdwelhTTnVhempraDBPS3lNLUpTTlFwUHd5dFpUUHpWM1c3U0FYZjFRYU04ZFlTN19ESndZSnlXTjRCN0d1WUpDMkFydm13Rk1OX3JvTkMxM1o4VjhDbXZFbnYtbGpR?oc=5","date":"2026-01-21","type":"pipeline","source":"Contract Pharma","summary":"Crystalys Therapeutics Taps Justin Thacker as CFO - Contract Pharma","headline":"Crystalys Therapeutics Taps Justin Thacker as CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNS2wyQlFITTJ2b2k1ZUR5V0gtdUowRnVFcTRlNXl3S2hFaW9fZzVZazlCRGtCVG5zOWk4WVlFRTdZZE1Fc0dnbzNHSkw5WnhxQUpCeDV4amlMVzhELVRJb1c0anBEbXdmRFhkMjJmYm1Ua21STloyS0hIdHlNVmpRd0o1bFhVRDF6QmVQQ2FFNm8zN2NQLWloMExPeFIxYjNYRGhYNHhLNzllRFU?oc=5","date":"2026-01-02","type":"pipeline","source":"Kalkine Media","summary":"Design Therapeutics Inc (NASDAQ:DSGN) Nasdaq Index Genetic Focus - Kalkine Media","headline":"Design Therapeutics Inc (NASDAQ:DSGN) Nasdaq Index Genetic Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPN3A4Tzc4Z0xJTnB2alJlWVEydWlhaWwzeWVNMFFzRWNESHdoNEx0TVRhYlBlclJldkNJak93MDB4NWtfX2h4VzhTQ0JUa3ZIUlhnZEV1OFNEcC16SU12RVVKSmdLbFNjRnlkQ2hzbGlsMDNrU3Z3SVlOcS0wN1ZfS2dnZUJnUQ?oc=5","date":"2025-11-20","type":"pipeline","source":"Seeking Alpha","summary":"Design Therapeutics stock up as RBC upgrades (DSGN:NASDAQ) - Seeking Alpha","headline":"Design Therapeutics stock up as RBC upgrades (DSGN:NASDAQ)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWG4zbm9ZM2ZwcGNoSHU5WHFuaUJzNVM2X0JiMFRlRlVMZUNXWWJpajFFVlJURl9meEhKOXBQTDAyQXNGeGk0NEJzX0plX0dFY2pTa2JyN1EtWmxyVG1zc2lKQ2g0TEMwdlZHSGFmbGJLU3dDcUJ0U25qcFkwNFY3elVBMWhkXzlqUmhqNWJCLTY4T0ZxRFd6di1DT1BneV9RM3FHdy1mUms3eElaT0FKSUlwTWdieXFDNDM1NUNTRlpKZDZvaXNsLU4zQ3pVcjZ5RmFKYk5vOA?oc=5","date":"2025-10-14","type":"deal","source":"Reuters","summary":"US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership - Reuters","headline":"US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQNFZqVGpZTmRpOWlzLVhud3p2SUhZVjVOV0EwSGw2bGNJTHBhcHJpVUVsdXJETWltQ0IzVy1oakNwZkZLb1RmektKbU95aWR1R1kyU19WNXpwaGdiYlRxb2gxcklCX29INlJxOXRqNm9KelZtd0pwLXZZTl9UMXpVcnl6b0ZPMHlmQnhyQzhZcGxrNVVvQjhMcVZHZ1pBdw?oc=5","date":"2025-06-19","type":"pipeline","source":"Pharmaceutical Technology","summary":"Draig Therapeutics funding for neuropsychiatric disorder therapies - Pharmaceutical Technology","headline":"Draig Therapeutics funding for neuropsychiatric disorder therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxPWnFfOWREYThxYkhaWmoyVGZTemlmWlRzMXFHcllFWldMQjY4WldJRDZneUpHTHdpSXlzR1NDREtUcnNFY3h3RGhPdGI1Yi1LWUpvZGtxQzRpRV9McVNkOHlhNC1NT3VFUG1QRjdISTgyV3ZxSXhfMWdzWXFtN1d5eTY1NjU0S3BrVGljMTQxTTFoMWpkNVZRWUZsZlVOSFhyY0hCY09nZzQwREw3SFdrSlJFb2dKLUo5Y0NxdEsxMnlQTHdxajc5SE1mcDIwNHJyUXh2RXdxci1rNXpRWnNpZGNVTm5VZENrRXMyLS1hcTkwUlNnSWpTcURPOF9TMWNBSWF4NXpKUF90U1IxczZQOFFiZ2JCYUpJZkE?oc=5","date":"2025-06-05","type":"pipeline","source":"PR Newswire","summary":"Friedreich's Ataxia Market Poised for Rapid Expansion During the Forecast Period (2025-2034) as Drug Pipeline Gains Momentum | DelveInsight - PR Newswire","headline":"Friedreich's Ataxia Market Poised for Rapid Expansion During the Forecast Period (2025-2034) as Drug Pipeline Gains Mome","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}